Moreover, ectopic expression of MYB was sufficient to suppress CDK9 inhibitor-mediated apoptosis, strongly supporting the notion that MYB is a critical target of these inhibitors in ER+ve breast cancer cells. This evidence concerns the gene MYB and breast carcinoma.